These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7949498)

  • 1. Close clinical observation minimizes the complications of beta-blocker withdrawal.
    Eisele G; Gilmore LL; Blanchard EB
    Ann Pharmacother; 1994; 28(7-8):849-51. PubMed ID: 7949498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-Blocker withdrawal is preferable for accurate interpretation of the aldosterone-renin ratio in chronically treated hypertension.
    Browne GA; Griffin TP; O'Shea PM; Dennedy MC
    Clin Endocrinol (Oxf); 2016 Mar; 84(3):325-31. PubMed ID: 26300226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Blocker-Associated Risks in Patients With Uncomplicated Hypertension Undergoing Noncardiac Surgery.
    Jørgensen ME; Hlatky MA; Køber L; Sanders RD; Torp-Pedersen C; Gislason GH; Jensen PF; Andersson C
    JAMA Intern Med; 2015 Dec; 175(12):1923-31. PubMed ID: 26436291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-adrenergic blocker withdrawal.
    Frishman WH
    Am J Cardiol; 1987 May; 59(13):26F-32F. PubMed ID: 2883874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Beta-blocker withdrawal syndrome].
    Goliakov VN; Zimin IuV
    Klin Med (Mosk); 1984 Mar; 62(3):15-22. PubMed ID: 6143853
    [No Abstract]   [Full Text] [Related]  

  • 6. [Takotsubo cardiomyopathy: a novel beta-adrenergic blocker withdrawal syndrome].
    Tomcsányi J; Jávor K; Arabadzisz H; Zsoldos A; Wagner V; Sármán B
    Orv Hetil; 2013 Feb; 154(7):267-71. PubMed ID: 23395791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The beta-adrenoceptor blocker withdrawal syndrome].
    Jørgensen PH; Jespersen C
    Ugeskr Laeger; 1985 Apr; 147(18):1470-3. PubMed ID: 2861678
    [No Abstract]   [Full Text] [Related]  

  • 8. Haemodynamic effects of withdrawal of long-term treatment with beta-adrenoceptor blocking agents in subjects with essential hypertension.
    Bengtsson C; Larsson Y; Panfilov V; Sivertsson R; Aström H
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():421s-423s. PubMed ID: 6119181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Withdrawal syndromes and the cessation of antihypertensive therapy.
    Hart GR; Anderson RJ
    Arch Intern Med; 1981 Aug; 141(9):1125-7. PubMed ID: 6114720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Change from ACE inhibitor, Ca-antagonist or beta-blocker to candesartan cilexetil: better efficacy and tolerance. SWITCH study (German study segment)].
    Baumgart P; Reismann J; Pohlmeyer H; Düsing R
    Dtsch Med Wochenschr; 2001 May; 126(19):547-50. PubMed ID: 11402910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-adrenergic blocker withdrawal syndromes in hypertension and other cardiovascular diseases.
    Houston MC; Hodge R
    Am Heart J; 1988 Aug; 116(2 Pt 1):515-23. PubMed ID: 2899971
    [No Abstract]   [Full Text] [Related]  

  • 12. The relative risk of incident coronary heart disease associated with recently stopping the use of beta-blockers.
    Psaty BM; Koepsell TD; Wagner EH; LoGerfo JP; Inui TS
    JAMA; 1990 Mar 23-30; 263(12):1653-7. PubMed ID: 1968518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
    JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase of 1-year mortality after perioperative beta-blocker withdrawal in endovascular and vascular surgery patients.
    Hoeks SE; Scholte Op Reimer WJ; van Urk H; Jörning PJ; Boersma E; Simoons ML; Bax JJ; Poldermans D
    Eur J Vasc Endovasc Surg; 2007 Jan; 33(1):13-9. PubMed ID: 16935011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autonomic antecedents to variant angina exacerbation after beta-blockade withdrawal.
    Chiladakis JA; Alexopoulos D
    J Electrocardiol; 2005 Jan; 38(1):82-4. PubMed ID: 15660353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Problems caused by withdrawal of beta blockers].
    Gadeholt G
    Tidsskr Nor Laegeforen; 1990 May; 110(12):1543-4. PubMed ID: 1971125
    [No Abstract]   [Full Text] [Related]  

  • 17. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW
    Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative beta-blocker withdrawal and mortality in vascular surgical patients.
    Shammash JB; Trost JC; Gold JM; Berlin JA; Golden MA; Kimmel SE
    Am Heart J; 2001 Jan; 141(1):148-53. PubMed ID: 11136500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug withdrawal symptoms following treatment with beta-receptor blockaders].
    Gilfrich HJ; Rahn KH
    Med Welt; 1981 Jun; 32(26):1036-7. PubMed ID: 6114382
    [No Abstract]   [Full Text] [Related]  

  • 20. Withdrawal of antihypertensive medications.
    Froom J; Trilling JS; Yeh SS; Gomolin IH; Filkin AM; Grimson RC
    J Am Board Fam Pract; 1997; 10(4):249-58. PubMed ID: 9228619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.